Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Xenon Pharmaceuticals
Over the past year AMLX returned +112.2% and XENE returned −9.0%; their daily moves had a correlation of 0.22.
AMLX +112.2% XENE −9.0%Growth of $1, one year, split-adjusted
| Metric | AMLX | XENE |
|---|---|---|
| Price | $28.86 | $37.41 |
| Market cap | $3.62B | $3.62B |
| Today | +0.63% | −0.35% |
| 1 month | +2.8% | −3.9% |
| 6 months | +80.3% | −33.4% |
| Year to date | +138.9% | −16.5% |
| 1 year | +107.8% | −11.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $250.8M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 112.7% | 82.3% |
| Short % of float | 13.7% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).